Healthcare of Ontario Pension Plan Trust Fund Acquires Shares of 2,000,000 Drugs Made In America Acquisition II Corp. $DMII

Healthcare of Ontario Pension Plan Trust Fund bought a new position in shares of Drugs Made In America Acquisition II Corp. (NASDAQ:DMII) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 2,000,000 shares of the company’s stock, valued at approximately $19,960,000.

Several other institutional investors have also recently made changes to their positions in DMII. Deltec Asset Management LLC purchased a new position in shares of Drugs Made In America Acquisition II in the 4th quarter valued at approximately $495,000. Wolverine Asset Management LLC purchased a new stake in Drugs Made In America Acquisition II in the fourth quarter worth $10,521,000. ABC Arbitrage SA bought a new position in Drugs Made In America Acquisition II in the fourth quarter worth $396,000. Wealthspring Capital LLC bought a new position in Drugs Made In America Acquisition II in the fourth quarter worth $4,049,000. Finally, HighTower Advisors LLC purchased a new position in Drugs Made In America Acquisition II during the fourth quarter valued at $7,817,000.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on DMII shares. Weiss Ratings upgraded shares of Drugs Made In America Acquisition II from a “sell (e)” rating to a “sell (e+)” rating in a report on Thursday, June 11th. Wall Street Zen upgraded shares of Drugs Made In America Acquisition II from a “sell” rating to a “hold” rating in a research note on Sunday, May 10th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Drugs Made In America Acquisition II presently has an average rating of “Sell”.

Drugs Made In America Acquisition II Stock Performance

NASDAQ DMII opened at $10.10 on Tuesday. Drugs Made In America Acquisition II Corp. has a 12 month low of $9.86 and a 12 month high of $10.11. The business has a fifty day moving average of $10.08.

Drugs Made In America Acquisition II Company Profile

Drugs Made In America Acquisition II (NASDAQ:DMII) is a special purpose acquisition company (SPAC) formed to raise capital through a public listing for the purpose of effecting a business combination. As a blank‑check vehicle, the company itself does not operate a traditional commercial business; instead, it seeks to identify, negotiate and complete an acquisition, merger, share exchange, asset purchase or similar business transaction with one or more target companies.

The stated investment focus reflected in the company’s name indicates an emphasis on the pharmaceutical and life sciences sector, with a particular interest in domestic drug manufacturing, supply‑chain resiliency and related healthcare operations in the United States.